Overdose Prevention Centers and Behavioral Health
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Overdose. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Assessing the Impact of Overdose Prevention Centers as a Polysubstance Use and Behavioral Health Intervention in New York City
Overview
The aims of this study are: (Aim 1) Identify sources of heterogeneous impacts of opioid prevention center (OPC) use on non-fatal and fatal overdose risk among individuals with histories of polysubstance use (PSU); (Aim 2) Estimate the impact of OPC use on treated psychiatric events among clients with histories of PSU, and; (Aim 3) Assess the barriers and facilitators of integrating mental health services into existing syringe service and OPC delivery models.
Detailed description
Aims 1 and 2 of this study will use secondary data to identify sources of heterogeneous impacts of OPC use on fatal and nonfatal overdose risk (Aim 1) and estimate the impact of OPC use on treated psychiatric events among clients with histories of PSU (Aim 2). Aim 3 of this study will use qualitative interviews with harm reduction staff to assess barriers and facilitators of integrating mental health services into existing syringe service and OPC delivery models.
Primary outcome measures
- Incidence of Fatal Overdose [Time frame: Up to Month 12]
- Incidence of Non-Fatal Overdose [Time frame: Up to Month 12]
- Incidence of Psychiatric Services Utilization [Time frame: Up to Month 12]
Eligibility criteria
Inclusion criteria
Aims 1 and 2:
- are 18 years of age or older;
- engaged in syringe service program and/or overdose prevention center services in New York City in the past 30 days before the date of enrollment;
- are able to complete assessments in English or Spanish;
- are competent to give written informed consent at the time of the interview;
- are able to provide informed consent;
- self-report use of illicit opioids (e.g., heroin, fentanyl), illicit stimulants (e.g., powder cocaine, crack, methamphetamine), counterfeit prescription pills (defined as prescription pills obtained through the illicit drug market) or any injection drug use in the past 30 days, and
- are able to participate for at least 6 months following enrollment.
Aim 3
- are 18 years of age or older;
- are employed by a harm reduction program;
- are able to complete assessments in English; and
- are able to provide informed consent.
Exclusion criteria
- Individuals not meeting the criteria detailed above for the respective Aims will not be eligible for participation in this study.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- NYU Langone Health — New York
Identifiers
NCT: NCT06236087 · 23-01594 · 23-A0-00-1010153